Depomed reported $4.53M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Aerie Pharmaceuticals AERI:US $ 3.74M 3.04M
Ani Pharmaceuticals ANIP:US $ 35.29M 1.02M
Aurora Cannabis Inc ACB:CN 103.36M 6.41M
Cara Therapeutics CARA:US 0 2.08M
Daiichi Sankyo 4568:JP Y 74798M 14032M
Depomed DEPO:US $ 4.53M 0.73M
Johnson & Johnson JNJ:US $ 7919M 321M
Knight Therapeutics Inc GUD:CN C$ 37.52M 6.19M
Merk MRK:US $ 3698M 1636M
Nektar Therapeutics NKTR:US $ 5.12M 0.2M
Pfizer PFE:US $ 8671M 1339M
Teva Pharmaceutical TEVA:IT 1.96B 99M